No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
BPTH Bio-Path Holdings
- 2.680
- +0.045+1.71%
Close Apr 26 16:00 ET
- 2.730
- +0.050+1.87%
Post 19:44 ET
4.20MMarket Cap-79P/E (TTM)
2.799High2.450Low117.22KVolume2.640Open2.635Pre Close312.05KTurnover7.77%Turnover RatioLossP/E (Static)1.57MShares44.80052wk High9.50P/B4.05MFloat Cap2.35052wk Low--Dividend TTM1.51MShs Float23999.988Historical High--Div YieldTTM13.26%Amplitude2.350Historical Low2.662Avg Price1Lot Size
Full Hours
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Bio-Path Holdings, Sunshine Biopharma, INVO Bioscience Among Healthcare Movers
Why Vaxxinity Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Vaxxinity, Inc. (NASDAQ:VAXX) fell sharply during Monday's session after the company announced its intention to voluntarily delist and deregister its Class A common stock.
MRIN, WISA and SMFL Among Mid-day Movers
12 Health Care Stocks Moving In Monday's Intraday Session
GainersNKGen Biotech (NASDAQ:NKGN) shares rose 33.8% to $1.48 during Monday's regular session. The company's market cap stands at $33.7 million. The company's, Q4 earnings came out 4 days ago. MSP Rec
Lexicon Pharmaceuticals, Bio-Path Holdings, Protara Therapeutics Among Healthcare Movers
Express News | Bio-Path Holdings, Inc. Announces Closing of $1.2 Million Registered Direct Offering Priced at-the-Market Under Nasdaq Rules
Comments
$Bio-Path Holdings(BPTH.US$
NEWS
Bio-Path Holdings, Inc. Announces Closing of $1.2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
NEWS
Bio-Path Holdings, Inc. Announces Closing of $1.2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
$Bio-Path Holdings(BPTH.US$ offering closed pump to be resumed
Biotechnology Company Announces Successful Clinical Trial Completion For Leukemia Treatment
A Beacon of Hope: Bio-Path Holdings' Groundbreaking Progress in AML Treatment.
In a significant stride toward combating refractory/relapsed acute myeloid leukemia (AML), Bio-Path Holdings, Inc. has recently announced the successful completion of the second dose cohort in the dose escalation portion of its Phase 1/1b clinical trial of BP1002. This marks a pivotal moment in the ongoing battle against one of...
In a significant stride toward combating refractory/relapsed acute myeloid leukemia (AML), Bio-Path Holdings, Inc. has recently announced the successful completion of the second dose cohort in the dose escalation portion of its Phase 1/1b clinical trial of BP1002. This marks a pivotal moment in the ongoing battle against one of...
$Bio-Path Holdings(BPTH.US$ run it up
1
$Bio-Path Holdings(BPTH.US$ SHORT = LAO OTHER BROKERS NHAO 🤩
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg